Skip to content
10-Q

Quarterly Report

NUTRA PHARMA CORP. NPHC

0001493152-25-019875

← back to feed
Filed
Oct 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 28, 2025 7.1B sh
Short Term Debt Q3 2023 · Sep 30, 2023 $8.21M
Short Term Debt Q3 2023 · Dec 31, 2022 $7.93M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $0
Cash And Equivalents Q3 2023 · Dec 31, 2022 $0
Current Liabilities Q3 2023 · Sep 30, 2023 $13.95M
Current Liabilities Q3 2023 · Dec 31, 2022 $12.7M
Total Liabilities Q3 2023 · Sep 30, 2023 $14.24M
Total Liabilities Q3 2023 · Dec 31, 2022 $13.13M
Current Assets Q3 2023 · Sep 30, 2023 $363.84K
Current Assets Q3 2023 · Dec 31, 2022 $333.58K
Total Assets Q3 2023 · Sep 30, 2023 $711.34K
Total Assets Q3 2023 · Dec 31, 2022 $754.91K
Shares Diluted Q3 2023 · Sep 30, 2022 15.6B sh
Shares Diluted Q3 2023 · Sep 30, 2022 15.1B sh
Capex Q3 2023 · Sep 30, 2022 $57.99K
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$708.4K
Stockholders Equity Q3 2023 · Sep 30, 2022 −$15.61M
Stockholders Equity Q3 2023 · Jun 30, 2022 −$16.2M
Stockholders Equity Q3 2023 · Dec 31, 2021 −$20.88M
Eps Diluted Q3 2023 · Sep 30, 2022 $0.00
Eps Diluted Q3 2023 · Sep 30, 2022 $0.00
Eps Basic Q3 2023 · Sep 30, 2022 $0.00
Eps Basic Q3 2023 · Sep 30, 2022 $0.00
Sga Expense Q3 2023 · Sep 30, 2022 $326.47K
Sga Expense Q3 2023 · Sep 30, 2022 $991.56K
Net Income Q3 2023 · Sep 30, 2022 $577.23K
Net Income Q3 2023 · Sep 30, 2022 $4.94M
Operating Income Q3 2023 · Sep 30, 2022 −$236.52K
Operating Income Q3 2023 · Sep 30, 2022 −$886.03K
Gross Profit Q3 2023 · Sep 30, 2022 $68.15K
Gross Profit Q3 2023 · Sep 30, 2022 $105.53K
Revenue Q3 2023 · Sep 30, 2022 $24.62K
Revenue Q3 2023 · Sep 30, 2022 $66.81K